Validation of HER2 Testing in Endometrial Serous Carcinoma

被引：0
|
作者：
Zyla, Roman [1 ]
Wing, Anthony [2 ]
Jimenez, Jenny [2 ]
White, John [2 ]
Seebocus, Neha [2 ]
Turashvili, Gulisa [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[3] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
799
引用
收藏
页码：860 / 860
页数：1
相关论文
共 50 条
  • [41] HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma
    Stelter, Bradly
    Nhu Vu
    Cagaanan, Alain
    Al-Niaimi, Ahmed
    Weisman, Paul
    McGregor, Stephanie
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1139 - 1139
  • [42] HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma
    Cagaanan, Alain
    Stelter, Bradly
    Vu, Nhu
    Rhode, Erin N.
    Stewart, Theresa
    Hui, Pei
    Buza, Natalia
    Al-Niaimi, Ahmed
    Flynn, Christopher
    Weisman, Paul S.
    McGregor, Stephanie M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2022, 41 (02) : 132 - 141
  • [43] HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma
    Stelter, Bradly
    Nhu Vu
    Cagaanan, Alain
    Al-Niaimi, Ahmed
    Weisman, Paul
    McGregor, Stephanie
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1139 - 1139
  • [44] ER, PR, and HER2/neu in endometrial carcinoma - a clinicopathological study
    Duggal, J.
    Kaur, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 93 - 93
  • [45] HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
    Mcnamara, Blair
    Mutlu, Levent
    Greenman, Michelle
    Harold, Justin
    Santin, Alessandro
    CANCERS, 2023, 15 (16)
  • [46] Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
    Quddus, M. Ruhul
    Hansen, Katrine
    Tantravahi, Umadevi
    Sung, C. James
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 32
  • [47] Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer
    Rose, Peter G.
    Kelley, Johanna A.
    Feldman, Myra
    Krivanek, Kevin
    JCO PRECISION ONCOLOGY, 2023, 7
  • [48] Is "Polysomy" in Breast Carcinoma the "New Equivocal" in HER2 Testing?
    Swanson, Paul E.
    Yang, Hua
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 181 - 184
  • [49] HER2 and p95HER2 Protein Expression Varies in Primary Versus Metastatic Serous Endometrial Carcinomas
    Newell, Jordan M.
    Hossler, Carrie
    Warrick, Joshua I.
    Roche, Michael
    Kesterson, Joshua P.
    MODERN PATHOLOGY, 2018, 31 : 442 - 442
  • [50] HER2 and p95HER2 Protein Expression Varies in Primary Versus Metastatic Serous Endometrial Carcinomas
    Newell, Jordan M.
    Hossler, Carrie
    Warrick, Joshua I.
    Roche, Michael
    Kesterson, Joshua P.
    LABORATORY INVESTIGATION, 2018, 98 : 442 - 442
12345